Skip to main content
Erschienen in: International Urology and Nephrology 2/2012

01.04.2012 | Nephrology – Original Paper

Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center

verfasst von: Wang Yu, Sun Luying, Wang Haiyan, Li Xiaomei

Erschienen in: International Urology and Nephrology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Aim

Several studies have suggested that sodium intake may affect blood pressure (BP), proteinuria, and intrarenal transforming growth factor-β1 (TGF-β1) production in patients and animal models with chronic kidney disease (CKD). The Chinese population has a high prevalence of CKD and is well known for consuming salty foods. This study will investigate the role of dietary sodium intake on BP control among non-dialysis Chinese CKD patients.

Methods

A cross-sectional study was carried out in a cohort of 176 non-dialysis hypertensive CKD patients to investigate their sodium intake and its effect on BP control by measuring 24-h urine sodium excretion (24-h UNa). A total of 20 patients with immunoglobulin A nephropathy (IgAN) participated in a 7-day sodium restriction study (100 mmol/day). Their changes in BP, proteinuria, and urinary TGF-β1 excretion were subsequently analyzed. Another 23 IgAN patients without salt restriction were included as controls.

Results

The average 24-h UNa of the study cohort was 149.0 ± 66.4 mmol/day. Only 31.8% patients had a 24-h UNa less than 100 mmol/day. The OR for each 17 mmol increment in 24-h UNa (salt 1 g/day) for BP > 130/80 mmHg was 1.26 (95% CI 1.10–1.44, P = 0.001). The sodium restriction group achieved significantly more reduction in SBP (−11.1 mmHg vs. −5.0 mmHg, P = 0.022), DBP (−9.4 mmHg vs. −2.1 mmHg, P = 0.009), and urine protein excretion [−465 (−855 to −340) mg/day vs. −150 (−570 to 40) mg/day, P = 0.024]. A positive correlation was observed between the change of 24-h UNa and the change of SBP (r = 0.450, P = 0.047) in the sodium restriction group. The change of 24-h UNa was also correlated with the 24-h TGF-β1 excretion (r = 0.558, P = 0.011) in these patients.

Conclusion

Dietary sodium intake restriction should be monitored and intensified in the treatment of Chinese CKD patients.
Literatur
1.
Zurück zum Zitat Elliott P, Stamler J, Nichols R et al (1996) For the INTERSALT Cooperative Research Group: INTERSALT revisited: further analyses of 24 h urinary sodium excretion and blood pressure within and across populations. Br Med J 312:1249–1253CrossRef Elliott P, Stamler J, Nichols R et al (1996) For the INTERSALT Cooperative Research Group: INTERSALT revisited: further analyses of 24 h urinary sodium excretion and blood pressure within and across populations. Br Med J 312:1249–1253CrossRef
2.
Zurück zum Zitat Sacks FM, Svetkey LP, Vollmer WM et al (2001) DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344:3–10PubMedCrossRef Sacks FM, Svetkey LP, Vollmer WM et al (2001) DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344:3–10PubMedCrossRef
3.
Zurück zum Zitat Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ (1982) Salt sensitivity of blood pressure in chronic renal failure. Hypertension 4:190–197PubMed Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ (1982) Salt sensitivity of blood pressure in chronic renal failure. Hypertension 4:190–197PubMed
4.
Zurück zum Zitat Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ (1982) Salt handling in patients with chronic renal insufficiency. Miner Electrolyte Metab 7:134–145PubMed Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ (1982) Salt handling in patients with chronic renal insufficiency. Miner Electrolyte Metab 7:134–145PubMed
5.
Zurück zum Zitat Weir MR, Dengel DR, Behrens MT, Goldberg AP (1995) Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25:1339–1344PubMed Weir MR, Dengel DR, Behrens MT, Goldberg AP (1995) Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 25:1339–1344PubMed
6.
Zurück zum Zitat Vogt L, Waanders F, Boomsma F et al (2008) Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19:999–1007PubMedCrossRef Vogt L, Waanders F, Boomsma F et al (2008) Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19:999–1007PubMedCrossRef
7.
Zurück zum Zitat De Nicola L, Minutolo R, Chiodini P et al (2006) TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 69:538–545PubMedCrossRef De Nicola L, Minutolo R, Chiodini P et al (2006) TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 69:538–545PubMedCrossRef
8.
Zurück zum Zitat Van Zuilen AD, Wetzels JF, Bots ML, Van Blankestijn PJ (2008) MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol 21:261–267PubMed Van Zuilen AD, Wetzels JF, Bots ML, Van Blankestijn PJ (2008) MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol 21:261–267PubMed
9.
Zurück zum Zitat Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G (2000) Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 35:1155–1165PubMedCrossRef Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G (2000) Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 35:1155–1165PubMedCrossRef
10.
Zurück zum Zitat Sanders PW (2004) Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 43:142–146PubMedCrossRef Sanders PW (2004) Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 43:142–146PubMedCrossRef
11.
Zurück zum Zitat Yu HCM, Burrell LM, Black MJ et al (1998) Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621–2628PubMed Yu HCM, Burrell LM, Black MJ et al (1998) Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621–2628PubMed
12.
Zurück zum Zitat Cianciaruso B, Bellizzi V, Minutolo R et al (1998) Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 24:296–301PubMedCrossRef Cianciaruso B, Bellizzi V, Minutolo R et al (1998) Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 24:296–301PubMedCrossRef
13.
Zurück zum Zitat Sanders PW (2006) Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 15:54–60PubMedCrossRef Sanders PW (2006) Effect of salt intake on progression of chronic kidney disease. Curr Opin Nephrol Hypertens 15:54–60PubMedCrossRef
14.
Zurück zum Zitat Ying WZ, Sanders PW (1998) Dietary salt modulates renal production of transforming growth factor-β1 in rats. Am J Physiol 274:F635–F641PubMed Ying WZ, Sanders PW (1998) Dietary salt modulates renal production of transforming growth factor-β1 in rats. Am J Physiol 274:F635–F641PubMed
16.
Zurück zum Zitat Zhang L, Zhang P, Wang F et al (2008) Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 51:373–384PubMedCrossRef Zhang L, Zhang P, Wang F et al (2008) Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 51:373–384PubMedCrossRef
17.
Zurück zum Zitat Chen W, Chen W, Wang H et al (2009) Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 24:1205–1212PubMedCrossRef Chen W, Chen W, Wang H et al (2009) Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 24:1205–1212PubMedCrossRef
18.
Zurück zum Zitat Chen N, Wang W, Huang Y et al (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24:2117–2123PubMedCrossRef Chen N, Wang W, Huang Y et al (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24:2117–2123PubMedCrossRef
19.
Zurück zum Zitat Wang Y, Zhang L, Li X et al (2009) Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005. Hypertens Res 32:444–449PubMedCrossRef Wang Y, Zhang L, Li X et al (2009) Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005. Hypertens Res 32:444–449PubMedCrossRef
21.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR et al. (2003) Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 289:2560–2572 Chobanian AV, Bakris GL, Black HR et al. (2003) Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 289:2560–2572
22.
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A et al. (2007) Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105-1187 Mancia G, De Backer G, Dominiczak A et al. (2007) Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105-1187
23.
Zurück zum Zitat Kidney Disease Outcome Quality Initiative (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation classification stratification. Am J Kidney Dis 39(suppl 2):S1–S246 Kidney Disease Outcome Quality Initiative (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation classification stratification. Am J Kidney Dis 39(suppl 2):S1–S246
24.
Zurück zum Zitat Ma YC, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944PubMedCrossRef Ma YC, Zuo L, Chen JH et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944PubMedCrossRef
25.
Zurück zum Zitat Boudville N, Ward S, Benaroia M, House A (2004) Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 18:1300–1305CrossRef Boudville N, Ward S, Benaroia M, House A (2004) Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 18:1300–1305CrossRef
26.
Zurück zum Zitat Konishi Y, Okada N, Okamura M et al (2001) Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension 38:81–85PubMed Konishi Y, Okada N, Okamura M et al (2001) Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension 38:81–85PubMed
Metadaten
Titel
Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center
verfasst von
Wang Yu
Sun Luying
Wang Haiyan
Li Xiaomei
Publikationsdatum
01.04.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-9986-x

Weitere Artikel der Ausgabe 2/2012

International Urology and Nephrology 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.